Dr. Brian Druker, director of the Knight Cancer Institute at Oregon Health & Science University, championed the drug that became Gleevec. When Mel Mann was diagnosed with cancer at 37 years old, he ...
Get the latest on the science of healthy living in the NPR Health newsletter, sent weekly. When Mel Mann was diagnosed with cancer at 37 years old, he was told he'd have three years to live. It was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results